Genenta Science SPA (Genenta Science SPA) Operating Cash Flow per Share : $-0.67 (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Genenta Science SPA Operating Cash Flow per Share?

Genenta Science SPA's operating cash flow per share for the six months ended in Dec. 2023 was $-0.22. Genenta Science SPA's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.67.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -14.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Genenta Science SPA's Operating Cash Flow per Share or its related term are showing as below:

GNTA' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -34 Med: -24.3 Max: -14.6
Current: -14.6

During the past 5 years, Genenta Science SPA's highest 3-Year average Operating Cash Flow per Share Growth Rate was -14.60% per year. The lowest was -34.00% per year. And the median was -24.30% per year.

GNTA's 3-Year OCF Growth Rate is ranked worse than
70.26% of 1234 companies
in the Biotechnology industry
Industry Median: 3.5 vs GNTA: -14.60

Genenta Science SPA Operating Cash Flow per Share Historical Data

The historical data trend for Genenta Science SPA's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genenta Science SPA Operating Cash Flow per Share Chart

Genenta Science SPA Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

-0.19

-0.50

-0.52

-0.43

-0.67

Genenta Science SPA Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial				-0.14	-0.15	-0.28	-0.45	-0.22

Competitive Comparison of Genenta Science SPA's Operating Cash Flow per Share

For the Biotechnology subindustry, Genenta Science SPA's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genenta Science SPA's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genenta Science SPA's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Genenta Science SPA's Price-to-Operating-Cash-Flow falls into.

Genenta Science SPA Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Genenta Science SPA's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-12.219	/	18.217
	=	-0.67

Genenta Science SPA's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	-3.953	/	18.217
	=	-0.22

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.67

Genenta Science SPA Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Genenta Science SPA's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Genenta Science SPA (Genenta Science SPA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genenta Science SPA (NAS:GNTA) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

K5F:Germany

Address

Via Olgettina No. 58, Milan, ITA, 20132

Website

https://www.genenta.com

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's lead product includes Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.